All In Biotech

Drug Trial Radar · NCT03592121

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Last checked: Nov 19, 2026Latest source record: Mar 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

3

Actual

Start

Jul 9, 2018

Primary completion

Oct 12, 2019

Study completion Oct 12, 2019

Sponsor

Lead sponsor
Applied Biology, Inc.Industry
Sponsor type
Industry
First posted
Jul 19, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research study is to investigate the possibility that a topical drug could restore nipple sensitivity and improve sexual quality of life in breast cancer survivors.

Conditions

  • Sexual Dysfunction
  • Sexual Arousal Disorder
  • Sexual Dysfunction, Physiological
  • Breast Cancer
  • Nipple Disorder
  • Neuropathy
  • Cancer of Breast

Interventions

  • AB-101Drug

    Apply approximately 1 hour prior to sexual activity

  • PlaceboDrug

    Apply approximately 1 hour prior to sexual activity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Delayed Orgasm GradeTime frame: [baseline, week 8]

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Southern CA Center for Sexual Health and Survivorship Medicine

    Newport Beach, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.